EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C45H72O18 |
| Net Charge | 0 |
| Average Mass | 901.053 |
| Monoisotopic Mass | 900.47187 |
| SMILES | [H][C@@]12CC=C3C[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)CC[C@]3(C)[C@@]1([H])CC[C@]1(C)[C@@](O)([C@@H](C)C(=O)CCC(C)C)[C@@H](O[C@@H]3OC[C@H](O)[C@H](O[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@H]3OC(C)=O)C[C@@]21[H] |
| InChI | InChI=1S/C45H72O18/c1-20(2)7-10-28(48)21(3)45(56)32(62-42-39(59-22(4)47)38(30(50)19-58-42)63-40-36(54)33(51)29(49)18-57-40)16-27-25-9-8-23-15-24(11-13-43(23,5)26(25)12-14-44(27,45)6)60-41-37(55)35(53)34(52)31(17-46)61-41/h8,20-21,24-27,29-42,46,49-56H,7,9-19H2,1-6H3/t21-,24-,25+,26-,27-,29+,30-,31+,32-,33-,34+,35-,36+,37+,38-,39+,40-,41+,42-,43-,44-,45+/m0/s1 |
| InChIKey | FOCIGGVGHNGKRW-SWPAXGJUSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Galtonia candicans (ncbitaxon:81751) | bulb (BTO:0000159) | PubMed (11515577) | |
| Ornithogalum thyrsoides (ncbitaxon:484172) | bulb (BTO:0000159) | PubMed (12398536) |
| Roles Classification |
|---|
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyloxy]cholest-5-en-22-one (CHEBI:65622) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyloxy]cholest-5-en-22-one (CHEBI:65622) has role metabolite (CHEBI:25212) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyloxy]cholest-5-en-22-one (CHEBI:65622) is a 17-hydroxy steroid (CHEBI:36838) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyloxy]cholest-5-en-22-one (CHEBI:65622) is a acetate ester (CHEBI:47622) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyloxy]cholest-5-en-22-one (CHEBI:65622) is a cholestanoid (CHEBI:50401) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyloxy]cholest-5-en-22-one (CHEBI:65622) is a steroid saponin (CHEBI:61655) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyloxy]cholest-5-en-22-one (CHEBI:65622) is a β-D-glucoside (CHEBI:22798) |
| IUPAC Name |
|---|
| (3β,16β,20R)-16-{[2-O-acetyl-3-O-(β-D-xylopyranosyl)-α-L-arabinopyranosyl]oxy}-17-hydroxy-22-oxocholest-5-en-3-yl β-D-glucopyranoside |
| Citations |
|---|